This report displays the potential drug interactions between alprazolam and Vyvanse (lisdexamfetamine). No interactions were found between the two drugs. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Alprazolam is a benzodiazepine and is used to treat various conditions. A total of 538 drugs are known to interact with alprazolam.
Vyvanse is a CNS stimulant and is used to treat various conditions. A total of 340 drugs are known to interact with Vyvanse.
Grapefruit and grapefruit juice may interact with alprazolam and lead to potentially dangerous side effects. Discuss the use of grapefruit products with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. Do not drink alcohol while taking alprazolam. This medication can increase the effects of alcohol. You may feel more drowsy, dizzy, or tired if you take alprazolam with alcohol. Talk to your doctor or pharmacist if you have any questions or concerns.
Using lisdexamfetamine together with alcohol can increase the risk of cardiovascular side effects such as increased heart rate, chest pain, or blood pressure changes. You should avoid or limit the use of alcohol while being treated with lisdexamfetamine. Let your doctor know if you experience severe or frequent headaches, chest pain, and/or a fast or pounding heartbeat. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
No warnings were found for the selected drugs. Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication. Major interactions are highly clinically significant and should be avoided; moderate interactions are moderately clinically significant and should usually be avoided; minor interactions are minimally clinically significant and may be acceptable in some cases; unknown interactions have no known risk or benefit and should be avoided.